ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,271, issued on June 24, was assigned to JIANGNAN UNIVERSITY (Jiangsu, China).

"Fusion protein including GIP and FGF21 and compositions thereof" was invented by Shenglong Zhu (Wuxi, China) and Yongquan Chen (Wuxi, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a fusion protein for treating metabolic diseases, and a preparation method and use thereof. The fusion protein has a general formula of R1-L-R2 or R2-L-R1, wherein R1 is FGF21 protein, an FGF21 protein analog, or a similar peptide with the biological function of FGF21 protein; R2 is GIP, mutant GIP or a similar peptide with the biological function of GIP; and L is a...